Teva Pharmaceuticals USA confirmed a voluntary recall to all consumers/user level of 29 lots of single & 51 lots of combination Actavis valsartan medicines. This includes any products whose active ingredient is valsartan or valsartan and hydrochlorothiazide.
This voluntary recall was issued after trace amounts of N-nitrosodimethylamine (NDMA) were discovered in valsartan products. It should be noted that this recall also follows a mandated recall by the FDA – the agency issued a full recall of all blood pressure and heart failure medication with the active ingredient valsartan or valsartan and hydrochlorothiazide.
